Posts

Tevogen to go public in $1.2bn SPAC deal

The T-cell therapeutics company expects to be listed on the NYSE after deal comp...

STAT+: Trump demands the U.S. pay no more for drugs tha...

In Trump fashion, the former president claimed in a video announcement that he i...

A replacement for race: Medical experts explore how to ...

“Some of these things are just low-hanging fruit,” said David Jones, professor a...

Gates Foundation to fund trial of long-awaited new tube...

“If this vaccine could reduce the disease by 50%, that has tremendous implicatio...

Opinion: Smoke from Canadian wildfires shows outdoor wo...

The smoke from Canadian fires illuminates the lack of government policies and pr...

STAT+: Pharmalittle: FDA declines to approve higher dos...

The FDA declined to approve a higher-dose version of a Regeneron Pharmaceuticals...

STAT+: Moonlake’s less-than-transparent data disclosure...

In its recent data presentation, the biotech Moonlake Immunotherapeutics was les...

Opinion: Listen: Cancer drug shortages should be causin...

“Patients are already … terrified. The last thing they want to hear is that some...

When young people survive cancer, their mental-health s...

"It's not just grief over a shortened life, because a lot of people survive — bu...

STAT+: ‘It’s like Groundhog Day’: The cancer drug short...

An oncologist laments, “These shortages are preventable. They’re absolutely prev...

Opinion: It’s past time to address the problem of indoo...

Indoor air quality is a public health issue.

STAT+: Protesters slam health insurance lobby for Medic...

Hundreds of activists rallied outside of AHIP's headquarters to protest restrict...

STAT+: FDA issues warning to wholesaler sued by Gilead ...

The FDA has issued a warning to a drug wholesaler that was also sued by Gilead a...

STAT unveils a new look, and color. Our executive edito...

STAT has unveiled a new homepage redesign, and color. Our executive editor @rick...

STAT+: After late start, Eli Lilly has the momentum in ...

Lilly shows off data that suggests it could soon have a potent new injectable an...

STAT+: Global controversy heats up the race to build hu...

Scientists worry the recent controversy over human embryo models could lead to r...